Table 2.
Overview of study population characteristics among all newly diagnosed type 2 diabetics (T2D population) and five comorbidity populations (individuals undiagnosed with a comorbidity at the time of their first T2D diagnosis). T2D, type 2 diabetes; RFV, register feature vector; #, number of.
| T2D population | Heart failure | Myocardial infarction | |
|---|---|---|---|
| # Individuals | 203,517 | 190,819 | 190,987 |
| # Cases | — | 8,940 (4.69%) | 6,485 (3.40%) |
| # Non-cases | — | 181,879 (95.31%) | 184,502 (96.60%) |
| % Women | 47.03 | 47.52 | 48.14 |
| Median age at T2D diagnosis | 61.44 | 60.67 | 60.95 |
| Median # days until outcome | — | 1631.60 | 1537.80 |
| # Features in RFV | — | 6,155 | 6,155 |
| Stroke | Cardiovascular disease | Chronic kidney disease | |
| # Individuals | 191,095 | 120,114 | 200,646 |
| # Cases | 7,922 (4.15%) | 33,057 (27.52%) | 5,617 (2.80%) |
| # Non-cases | 183,173 (95.85%) | 87,057 (72.48%) | 195,029 (97.20%) |
| % Women | 47.38 | 49.77 | 47.18 |
| Median age at T2D diagnosis | 60.80 | 57.25 | 61.32 |
| Median # days until outcome | 1641.60 | 1414.00 | 2065.30 |
| # Features in RFV | 6,155 | 6,155 | 6,155 |